However, it is known that miR-145-5p can participate in cancer biology through the interactions with multiple downstream oncogenic or tumor suppressive signaling pathways, such as transforming growth factor-β signaling [18], β-catenin signaling [19], and TAGLN2 [20]. This evidence concerns the gene TAGLN2 and cancer.